Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine
|
January 8, 2026
B-cell activation underpins Rituximab response in focal segmental glomerulosclerosis
Liangjian Lu, Chang Yien Chan, Mya Than, et al.
Vaccines
|
December 23, 2023
SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
Liangjian Lu, Chang Yien Chan, Yi Yang Lim, et al.
Clinical Science (London, England : 1979)
|
January 15, 2020
IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease
Lauretta D Low, Liangjian Lu, Chang-Yien Chan, et al.
Clinical Science (London, England : 1979)
|
October 7, 2016
Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in interleukin-13-induced minimal change-like nephropathy
Chang-Yien Chan, Kar-Hui Ng, Jinmiao Chen, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
April 3, 2021
Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy
Chang-Yien Chan, Sharon Teo, Liangjian Lu, et al.
Cell Host & Microbe
|
November 3, 2019
Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance
Kar-Hui Ng, Summer Lixin Zhang, Hwee Cheng Tan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 9, 2016
T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS
Chang-Yien Chan, Isaac Desheng Liu, Lourdes Paula Resontoc, et al.
Pediatric Research
|
January 20, 2019
MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome
Chang-Yien Chan, Lourdes Paula Resontoc, Md Abdul Qader, et al.
Kidney International Reports
|
May 7, 2026
Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome
Eugene Yu-Hin Chan, Chun Ting Au, Ellen Lm Yu, et al.
Journal of the American Society of Nephrology : JASN
|
March 31, 2022
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study
Eugene Yu-Hin Chan, Ellen L M Yu, Andrea Angeletti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Translational Research : the Journal of Laboratory and Clinical Medicine
|
January 8, 2026
B-cell activation underpins Rituximab response in focal segmental glomerulosclerosis
Liangjian Lu, Chang Yien Chan, Mya Than, et al.
Vaccines
|
December 23, 2023
SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
Liangjian Lu, Chang Yien Chan, Yi Yang Lim, et al.
Clinical Science (London, England : 1979)
|
January 15, 2020
IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease
Lauretta D Low, Liangjian Lu, Chang-Yien Chan, et al.
Clinical Science (London, England : 1979)
|
October 7, 2016
Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in interleukin-13-induced minimal change-like nephropathy
Chang-Yien Chan, Kar-Hui Ng, Jinmiao Chen, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
April 3, 2021
Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy
Chang-Yien Chan, Sharon Teo, Liangjian Lu, et al.
Cell Host & Microbe
|
November 3, 2019
Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance
Kar-Hui Ng, Summer Lixin Zhang, Hwee Cheng Tan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 9, 2016
T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS
Chang-Yien Chan, Isaac Desheng Liu, Lourdes Paula Resontoc, et al.
Pediatric Research
|
January 20, 2019
MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome
Chang-Yien Chan, Lourdes Paula Resontoc, Md Abdul Qader, et al.
Kidney International Reports
|
May 7, 2026
Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome
Eugene Yu-Hin Chan, Chun Ting Au, Ellen Lm Yu, et al.
Journal of the American Society of Nephrology : JASN
|
March 31, 2022
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study
Eugene Yu-Hin Chan, Ellen L M Yu, Andrea Angeletti, et al.
Page
of 2